{
 "id": "851056",
 "text": "The CureVac COVID-19 vaccine was a COVID-19 vaccine candidate created by CureVac N.V. and the Coalition for Epidemic Preparedness Innovations (CEPI). The vaccine showed bad results in its Phase III trials with only 47% effective. The vaccine was never sold. ==References== Category:COVID-19 pandemic",
 "title": "CureVac COVID-19 vaccine"
}